The section of Molecular and Cellular Immunology at ICH researches into the molecular basis of primary immunodeficiency disorders, and other related haematopoietic disorders and is developing improved forms of treatment. One such form of treatment is somatic gene therapy, which has become a reality with the initiation of clinical trials for three life-threatening primary immunodeficiency disorders.
Professor Persis Amrolia is Head of the Section of Molecular and Cellular Immunology. The section comprises over 70 basic and clinical scientists, ranging from laboratory research assistants and graduate students to Consultant Immunologists and Professors. All scientists work as part of a team and on one or more problem related to the theme of our research.